Mitchell Sinkler & Starr »

United Therapeutics Corporation shares owned by Mitchell Sinkler & Starr

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Mitchell Sinkler & Starr from 13F filings

Historical chart of Mitchell Sinkler & Starr investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Mitchell Sinkler & Starr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Mitchell Sinkler & Starr

Quarter filed Position value Share count Share price at filing
2026-06-30 $241k 445 541.83

More positions owned by Mitchell Sinkler & Starr

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Vanguard Index Fds Total Stk Mkt (VTI)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Mitchell Sinkler & Starr

Top funds holding United Therapeutics Corporation

BlackRock
venBio Select Advisor
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Wellington Management Company
Geode Capital Management
Henderson Group
Jupiter Topco
Caption Management
Citadel Advisors
Susquehanna International
Norges Bank Investment Management
Assetmark

View all funds holding United Therapeutics Corporation